Strive Financial Group
TECH icon

Strive Financial Group’s Bio-Techne TECH Stock Holding History

Strive Financial Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.3K Buy
+18
New +$1.3K ﹤0.01% 1008

Other funds holding TECH

Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Geneva Capital Management
Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Strive Financial Group's TECH Position: Q3 2026 in Review

Strive Financial Group opened a new position in Bio-Techne (TECH) in Q3 2026: 18 shares worth $1.3K. The stake represents ﹤0.01% of the portfolio and ranks #1008 among its holdings.

301 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Strive Financial Group held 18 shares of Bio-Techne worth $1.3K as of Q3 2026.
  • Bio-Techne was a new Strive Financial Group position in Q3 2026.
  • Bio-Techne made up ﹤0.01% of Strive Financial Group's portfolio in Q3 2026, its #1008 holding.
  • 301 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Strive Financial Group's 13F filing for Q3 2026, filed 9 Nov 2026.